Related Experiment Video
Updated: Feb 3, 2026

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
[Research progress in therapeutic action of mesenchymal stem cell in allergic rhinitis]
1Department of Otorhinolaryngology Head and Neck Surgery, Affiliated Drum Tower Hospital of Nanjing University Medical School, Jiangsu Provincial Key Medical Discipline, Research Institution of Otorhinolaryngology, Drum Tower Hospital, Nanjing 210008, China.
Abstract:
Allergic rhinitis (AR) is an allergic disease of nasal mucosa, currently the consensus has been reached that there is a Th1/Th2 imbalance in AR's pathogenesis, meanwhile there are defects in the number and/or function of Treg cells. Mesenchymal stem cells (MSCs) have characteristics of multiple differentiation potential, low immunogenicity and immunomodulation function, which can be migrated and implanted into the nasal inflammatory mucosal, recovering the Th1/Th2 immune balance and up-regulate the Treg cells by immunomodulatory function to improve AR. For the present, the treatment of AR by MSCs is basically at the animal experiment stage. This paper reviews the progress of MSCs in AR's treatment and provides a basis for the clinical treatment of MSCs.
Related Concept Videos
Allergic Reactions
Mesenchymal Stem Cells
Adult Stem Cells
Allergic Drug Reactions
Embryonic Stem Cells
Fixed Action Patterns

